More about
Age-Adjusted Cancer
News
October 14, 2024
2 min read
Save
’Much work remains’ to ensure adequate diversity in trials of immune checkpoint inhibitors
Although progress has been made, lack of diversity continues to be problematic in trials of immune checkpoint inhibitors, according to study results.